IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function - PubMed (original) (raw)

IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function

P A Grant et al. EMBO J. 1995.

Abstract

The function of the temporally regulated B lymphocyte-specific immunoglobulin heavy chain (IgH) 3' enhancer has been linked to the IgH class switch machinery, but the physiological mechanism(s) of activation has not been discerned. Following crosslinking of the IgM receptor, we demonstrate that the enhancer is transactivated in the B lymphoma cell line BAL-17. In both induced primary B lymphocytes and BAL-17 cells, the enhancer activation is concomitant with the recruitment of a novel DNA binding complex, nuclear factor of activated B cells (NFAB). NFAB contains the tissue-restricted Ets protein Elf-1 and the AP-1 factors Jun-B and c-Fos, which bind to a novel 3' enhancer ETS-AP-1 motif. IgM receptor-mediated activation or stimulation by phorbol-ester in BAL-17 cells demonstrates that the ETS-AP-1 motif, when linked to a heterologous gene, can confer a ligand/receptor-dependent response. In NIH 3T3 cells, Elf-1 expression is required for efficient ETS-AP-1 promoter activity in response to stimulation by 12-O-tetradecanylphorbol 13-acetate. Our results suggest a biological role for Elf-1 in the regulation of IgH gene expression, attribute a functional role for receptor-induced AP-1 proteins in B lymphocytes and provide evidence for a direct link between IgM receptor-mediated signalling and 3' enhancer activation.

PubMed Disclaimer

Cited by

Evolutive emergence and divergence of an Ig regulatory node: An environmental sensor getting cues from the aryl hydrocarbon receptor?
D'Addabbo P, Frezza D, Sulentic CEW. D'Addabbo P, et al. Front Immunol. 2023 Feb 3;14:996119. doi: 10.3389/fimmu.2023.996119. eCollection 2023. Front Immunol. 2023. PMID: 36817426 Free PMC article. Review.
Aryl hydrocarbon receptor-induced activation of the human IGH hs1.2 enhancer: Mutational analysis of putative regulatory binding motifs.
Snyder AD, Ochs SD, Johnson BE, Sulentic CEW. Snyder AD, et al. Mol Immunol. 2020 Apr;120:164-178. doi: 10.1016/j.molimm.2020.02.002. Epub 2020 Mar 6. Mol Immunol. 2020. PMID: 32146146 Free PMC article.
JNK/AP1 Pathway Regulates MYC Expression and BCR Signaling through Ig Enhancers in Burkitt Lymphoma Cells.
Ding X, Wang X, Zhu X, Zhang J, Zhu Y, Shao X, Zhou X. Ding X, et al. J Cancer. 2020 Jan 1;11(3):610-618. doi: 10.7150/jca.34055. eCollection 2020. J Cancer. 2020. PMID: 31942184 Free PMC article.
Suppressive effect of Elf-1 on FcepsilonRI alpha-chain expression in primary mast cells.
Wang QH, Nishiyama C, Nakano N, Shimokawa N, Hara M, Kanada S, Ogawa H, Okumura K. Wang QH, et al. Immunogenetics. 2008 Oct;60(10):557-63. doi: 10.1007/s00251-008-0318-y. Epub 2008 Jul 16. Immunogenetics. 2008. PMID: 18629488
Burkitt lymphoma in the mouse.
Kovalchuk AL, Qi CF, Torrey TA, Taddesse-Heath L, Feigenbaum L, Park SS, Gerbitz A, Klobeck G, Hoertnagel K, Polack A, Bornkamm GW, Janz S, Morse HC 3rd. Kovalchuk AL, et al. J Exp Med. 2000 Oct 16;192(8):1183-90. doi: 10.1084/jem.192.8.1183. J Exp Med. 2000. PMID: 11034608 Free PMC article.

References

1. Gene. 1989 Apr 15;77(1):51-9 - PubMed
1. J Immunol. 1989 Aug 1;143(3):1032-9 - PubMed
1. Nature. 1990 Mar 8;344(6262):165-8 - PubMed
1. Mol Cell Biol. 1990 Jun;10(6):3145-54 - PubMed
1. Nature. 1990 Jul 12;346(6280):191-3 - PubMed

IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function - PubMed (original) (raw)